Found: 30
Select item for more details and to access through your institution.
Clinical effectiveness and safety of additional administration of tacrolimus in rheumatoid arthritis patients with an inadequate response to abatacept: A retrospective cohort study.
- Published in:
- International Journal of Rheumatic Diseases, 2019, v. 22, n. 12, p. 2199, doi. 10.1111/1756-185X.13731
- By:
- Publication type:
- Article
Comparison of the effects of baricitinib and tocilizumab on disease activity in patients with rheumatoid arthritis: a propensity score matching analysis.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 8, p. 3143, doi. 10.1007/s10067-021-05815-3
- By:
- Publication type:
- Article
Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 10, p. 2757, doi. 10.1007/s10067-019-04626-x
- By:
- Publication type:
- Article
Concomitant methotrexate has little effect on clinical outcomes of abatacept in rheumatoid arthritis: a propensity score matching analysis.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 9, p. 2451, doi. 10.1007/s10067-019-04581-7
- By:
- Publication type:
- Article
Improved safety of biologic therapy for rheumatoid arthritis over the 8-year period since implementation in Japan: long-term results from a multicenter observational cohort study.
- Published in:
- Clinical Rheumatology, 2016, v. 35, n. 4, p. 863, doi. 10.1007/s10067-016-3201-5
- By:
- Publication type:
- Article
Predictive factors for achieving low disease activity at 52 weeks after switching from tumor necrosis factor inhibitors to abatacept: results from a multicenter observational cohort study of Japanese patients.
- Published in:
- Clinical Rheumatology, 2016, v. 35, n. 1, p. 219, doi. 10.1007/s10067-015-3135-3
- By:
- Publication type:
- Article
Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies.
- Published in:
- Clinical Rheumatology, 2014, v. 33, n. 9, p. 1247, doi. 10.1007/s10067-014-2711-2
- By:
- Publication type:
- Article
Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity.
- Published in:
- Clinical Rheumatology, 2014, v. 33, n. 1, p. 39, doi. 10.1007/s10067-013-2392-2
- By:
- Publication type:
- Article
Effects of Concomitant Methotrexate on Large Joint Replacement in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors: A Multicenter Retrospective Cohort Study in Japan.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Longterm Retention Rate and Risk Factors for Adalimumab Discontinuation Due To Efficacy and Safety in Japanese Patients with Rheumatoid Arthritis: An Observational Cohort Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Use of a 12-week observational period for predicting low disease activity at 52 weeks in RA patients treated with abatacept: a retrospective observational study based on data from a Japanese multicentre registry study.
- Published in:
- Rheumatology, 2015, v. 54, n. 5, p. 854, doi. 10.1093/rheumatology/keu418
- By:
- Publication type:
- Article
Importance of methotrexate therapy concomitant with tocilizumab treatment in achieving better clinical outcomes for rheumatoid arthritis patients with high disease activity: an observational cohort study.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Importance of methotrexate therapy concomitant with tocilizumab treatment in achieving better clinical outcomes for rheumatoid arthritis patients with high disease activity: an observational cohort study.
- Published in:
- Rheumatology, 2015, v. 54, n. 1, p. 113, doi. 10.1093/rheumatology/keu302
- By:
- Publication type:
- Article
Predictors for clinical effectiveness of baricitinib in rheumatoid arthritis patients in routine clinical practice: data from a Japanese multicenter registry.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-78925-8
- By:
- Publication type:
- Article
A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and the effectiveness of abatacept in rheumatoid arthritis patients.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-76842-4
- By:
- Publication type:
- Article
Reasons and risk factors for discontinuation of treatment with any biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A long-term observational study.
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 5, p. 891, doi. 10.1093/mr/roac090
- By:
- Publication type:
- Article
Effectiveness of tacrolimus concomitant with biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 2, p. 292, doi. 10.1093/mr/roac025
- By:
- Publication type:
- Article
Higher doses of methotrexate associated with discontinuation of oral glucocorticoids after initiation of biological DMARDs: A retrospective observational study based on data from a Japanese multicenter registry study.
- Published in:
- Modern Rheumatology, 2021, v. 31, n. 4, p. 796, doi. 10.1080/14397595.2021.1879428
- By:
- Publication type:
- Article
Discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab: An interventional study.
- Published in:
- Modern Rheumatology, 2020, v. 30, n. 3, p. 434, doi. 10.1080/14397595.2019.1641934
- By:
- Publication type:
- Article
Clinical effectiveness and long-term retention of abatacept in elderly rheumatoid arthritis patients: Results from a multicenter registry system.
- Published in:
- Modern Rheumatology, 2019, v. 29, n. 6, p. 910, doi. 10.1080/14397595.2018.1525019
- By:
- Publication type:
- Article
Predictors of biologic discontinuation due to insufficient response in patients with rheumatoid arthritis who achieved clinical remission with biologic treatment: A multicenter observational cohort study.
- Published in:
- Modern Rheumatology, 2018, v. 28, n. 2, p. 221, doi. 10.1080/14397595.2017.1332558
- By:
- Publication type:
- Article
High rate of improvement in serum matrix metalloproteinase-3 levels at 4 weeks predicts remission at 52 weeks in RA patients treated with adalimumab.
- Published in:
- Modern Rheumatology, 2018, v. 28, n. 1, p. 119, doi. 10.1080/14397595.2017.1317320
- By:
- Publication type:
- Article
Comparison of efficacy and safety of tacrolimus and methotrexate in combination with abatacept in patients with rheumatoid arthritis; a retrospective observational study in the TBC Registry.
- Published in:
- Modern Rheumatology, 2015, v. 25, n. 6, p. 825, doi. 10.3109/14397595.2015.1029238
- By:
- Publication type:
- Article
Drug retention rates of second biologic agents after switching from tumor necrosis factor inhibitors for rheumatoid arthritis in Japanese patients on low-dose methotrexate or without methotrexate.
- Published in:
- Modern Rheumatology, 2015, v. 25, n. 2, p. 251, doi. 10.3109/14397595.2014.953668
- By:
- Publication type:
- Article
Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis.
- Published in:
- Modern Rheumatology, 2013, v. 23, n. 5, p. 977, doi. 10.3109/s10165-012-0782-y
- By:
- Publication type:
- Article
Clinical efficacy of abatacept in Japanese rheumatoid arthritis patients.
- Published in:
- Modern Rheumatology, 2013, v. 23, n. 5, p. 904, doi. 10.3109/s10165-012-0760-4
- By:
- Publication type:
- Article
A review of tocilizumab treatment in 122 rheumatoid arthritis patients included in the Tsurumai Biologics Communication Registry (TBCR) Study.
- Published in:
- Modern Rheumatology, 2013, v. 23, n. 2, p. 245, doi. 10.3109/s10165-012-0648-3
- By:
- Publication type:
- Article
Study protocol of a multicenter registry of patients with rheumatoid arthritis starting biologic therapy in Japan: Tsurumai Biologics Communication Registry (TBCR) Study.
- Published in:
- Modern Rheumatology, 2012, v. 22, n. 3, p. 339, doi. 10.1007/s10165-011-0518-4
- By:
- Publication type:
- Article
Early aggressive intervention with tocilizumab for rheumatoid arthritis increases remission rate defined using a Boolean approach in clinical practice.
- Published in:
- Modern Rheumatology, 2012, v. 22, n. 3, p. 370, doi. 10.3109/s10165-011-0528-2
- By:
- Publication type:
- Article
Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use.
- Published in:
- Rheumatology International, 2015, v. 35, n. 10, p. 1707, doi. 10.1007/s00296-015-3283-4
- By:
- Publication type:
- Article